Medical Communications
Sanofi and Glooko partner on ‘connected insulin’ tech
February 24, 2023 Medical Communications
Big pharma company Sanofi aims to develop insulin-based therapies that can be connected with glucose monitoring devices, making it easier …
Mologic Inc’s COVID-19 rapid antigen self-test receives FDA Emergency Use Authorization for home use
February 24, 2023 Medical Communications
US subsidiary of Global Access Diagnostics (GADx) ‒ a developer of lateral flow and rapid diagnostic technologies, products and services …
NICE approved BMS’s Opdivo for lung cancer
February 24, 2023 Medical Communications
Bristol-Myers Squibb’s (BMS) immunotherapy drug Opdivo (nivolumab) has become the first to be cleared for NHS use alongside chemotherapy as …
Moda Living and LloydsPharmacy partner to offer residents prescription service
February 24, 2023 Medical Communications
Moda Living has announced a partnership with LloydsPharmacy to bring residents a ‘Health Concierge Service’ through VideoGP. VideoGP will …
AstraZeneca signs $63m agreement for gastric cancer treatment
February 23, 2023 Medical Communications
AstraZeneca has announced that it has signed an exclusive license agreement (ELA) with KYM Biosciences Inc for CMG901, which is …
£1.6bn of research and development funding “surrendered” back to UK Treasury
February 23, 2023 Medical Communications
A pot of £1.6bn which was originally allocated as the UK’s contribution to the €96bn Horizon Europe research funding programme …
FDA approval granted to BD’s HPV assay for use with ThinPrep Pap Test
February 22, 2023 Medical Communications
Becton, Dickinson and Company (BD) has received FDA approval for its new HPV assay which will be used in testing …
Unum UK expands employee digital health app
February 21, 2023 Medical Communications
Employee benefits provider Unum UK has expanded its available modules on its Help@hand app, which aims to provide digital health …
CSL receives CMA from the European Commission for haemophilia B drug
February 21, 2023 Medical Communications
CSL, a biotech company, has announced that it has received conditional marketing authorisation (CMA) from the European Commission (EC) for …
FDA approves Apellis’ geographic atrophy treatment
February 20, 2023 Medical Communications
Apellis’ Syfovre (pegcetacoplan injection) is indicated for patients with geographic atrophy (GA) with or without subfoveal involvement, and has received …
Medtronic’s extravascular defibrillator receives CE mark
February 20, 2023 Medical Communications
Medtronic has received CE mark for its extravascular defibrillator. The Aurora EV-ICD™ MRI SureScan™ and Epsila EV™ MRI SureScan™ defibrillation …
Pfizer’s Lyme disease vaccine study cut due to protocol violations
February 20, 2023 Medical Communications
Valneva and Pfizer have seen their Lyme disease vaccine study cut down after some clinical trial sites were revealed to …
Sun Pharma recalls at least 34,000 bottles of generic drug
February 13, 2023 Medical Communications
Mumbai-based pharma company, Sun Pharma, has announced that it is recalling over 34,000 bottles of a generic drug, Diltiazem Hydrochloride, …
AstraZeneca moves manufacturing to Ireland due to Britain’s tax regime
February 10, 2023 Medical Communications
Big pharma giant, AstraZeneca, has announced that its plans to open a new facility in northwest England have now changed, …
FDA grants full approval to GSK for mismatch repair-deficient endometrial cancer treatment
February 10, 2023 Medical Communications
GSK announced that its treatment for recurrent or advanced mismatch repair-deficient (dMMR) endometrial cancer has been granted full approval by …
Latest content
October 26, 2026
